EU Decision Time On Broader Indication For AbbVie’s Skyrizi

Verdict Also Due On Expanding Olumiant’s Use As COVID-19 Treatment

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".